The president has persuaded U.S.-based companies to take action. President Donald Trump recently struck a deal with nine U.S. pharmaceutical companies, which will decrease prices for a large…
Read MorePrescriptions
FDA Adds Warning and Restrictions to Duchenne Gene Therapy
Updated labeling limits treatment to ambulatory children after reports of fatal liver failure in non-ambulatory patients. The U.S. Food and Drug Administration (FDA) has approved significant labeling changes…
Read More
HHS and FDA to Require Full Safety Disclosures in Drug Ads
Secretary Kennedy denounces pharmaceutical ads but does not advocate for ban. The Food and Drug Administration (FDA) began the process last week of rescinding a 1997 policy that…
Read More
FDA Approves Immunotherapy Treatment for Adult Respiratory Papillomatosis
Final reports from Precigen showed long-term effectiveness of the injections with reduced side effects. The Food and Drug Administration (FDA) has approved a drug manufactured by Precigen to…
Read More
FDA Updates Opioid Labels to Emphasize Long-Term Risks
New labeling rules follow evidence linking extended opioid use to serious health dangers, including addiction and overdose. The U.S. Food and Drug Administration (FDA) has mandated updated safety…
Read More
President Calls on Drug Makers to Reduce Prices Within 60 Days
Nearly half of prescription prices rose higher than the rate of inflation between 2022 and 2023. President Donald Trump sent letters to over a dozen pharmaceutical companies at…
Read More
CEO Convicted in $1B Medicare Fraud Scheme Targeting Seniors and Veterans
The executive and co-conspirators used fake medical orders and illegal kickbacks to exploit federal healthcare programs A federal jury has convicted Gary Cox, 79, CEO of Power Mobility…
Read More
FTC Issues Warnings to Eye Care Providers Over Prescription Rule Violations
37 prescribers and one major vision group cautioned following consumer complaints over illegal fees for prescription access. The Federal Trade Commission (FTC) sent warning letters to 37 contact…
Read More
Federal Agencies Request Public Input on Healthcare Price Transparency
The effort aligns with President Trump’s executive order on healthcare pricing. The Departments of Labor, Health and Human Services (HHS), and the Treasury recently issued a joint Request…
Read More
FTC Challenges Drug Patents Hindering Generic Competition
The agency renewed efforts to remove over 200 disputed patents from FDA’s Orange Book to promote affordable medication access. The Federal Trade Commission (FTC) recently renewed its challenge…
Read More